Please assess the completion status of the following clinical trial:

Trial Title: Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A woman between, and including, 10 and 25 years of age at the time of the first vaccination.~* Written informed consent from the subject prior to enrolment.~* Subject must be free of obvious health problems.~* Subject must have negative urine pregnancy test.~Exclusion Criteria:~* Pregnant or breastfeeding.~* Known acute or chronic, clinically significant pulmonary, cardiovascular, neurologic, hepatic or renal functional abnormality.~* History of chronic condition(s) requiring treatment such as cancer, chronic hepatitis or kidney disease(s), diabetes, or autoimmune disease.~* Previous vaccination against human papillomavirus (HPV).

- Gender: FEMALE
- Minimum Age: 10 Years
- Maximum Age: 25 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).